Serum placental growth factor and fms-like tyrosine kinase 1 during first trimester in Chinese women with pre-eclampsia – a case–control study

References

• LeungTY, LeungTN, SahotaDS, ChanOK, ChanLW, FungTY, LauTK. Trends in maternal obesity and associated risks of adverse pregnancy outcomes in a population of Chinese women. BJOG 2008;115:1529–1537.
   PubMed Web of Science ®Google Scholar
• PlasenciaW, MaizN, BoninoS, KaihuraC, NicolaidesKH. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 2007;30:742–749.
   PubMed Web of Science ®Google Scholar
• SpencerK, CowansNJ, NicolaidesKH. Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia. Prenat Diagn 2008;28:7–10.
   PubMed Web of Science ®Google Scholar
• LawLW, LeungTY, SahotaDS, ChanLW, FungTY, LauTK. Which ultrasound or biochemical markers are independent predictors of small-for-gestational age? Ultrasound Obstet Gynecol 2009;34:283–287.
   PubMed Web of Science ®Google Scholar
• AkolekarR, ZaragozaE, PoonLC, PepesS, NicolaidesKH. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 2008;32:732–739.
   PubMed Web of Science ®Google Scholar
• KimSY, RyuHM, YangJH, KimMY, HanJY, KimJO, ChungJH, ParkSY, LeeMH, KimDJ. Increased sFlt-1 to PlGF ratio in women who subsequently develop preeclampsia. J Korean Med Sci 2007;22:873–877.
   PubMed Web of Science ®Google Scholar
• ShibataE, RajakumarA, PowersRW, LarkinRW, GilmourC, BodnarLM, CrombleholmeWR, NessRB, RobertsJM, HubelCA. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J Clin Endocrinol Metab 2005;90:4895–4903.
   PubMed Web of Science ®Google Scholar
• LevineRJ, MaynardSE, QianC, LimKH, EnglandLJ, YuKF, SchistermanEF, ThadhaniR, SachsBP, EpsteinFH, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672–683.
   PubMed Web of Science ®Google Scholar
• ChappellLC, SeedPT, BrileyA, KellyFJ, HuntBJ, Charnock-JonesDS, MalletAI, PostonL. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol 2002;187:127–136.
   PubMed Web of Science ®Google Scholar
• PolliottiBM, FryAG, SallerDN, MooneyRA, CoxC, MillerRK. Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia. Obstet Gynecol 2003;101:1266–1274.
   PubMed Web of Science ®Google Scholar
• KraussT, PauerHU, AugustinHG. Prospective analysis of placenta growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia. Hypertens Pregnancy 2004;23:101–111.
   PubMed Web of Science ®Google Scholar
• SuYN, LeeCN, ChengWF, ShauWY, ChowSN, HsiehFJ. Decreased maternal serum placenta growth factor in early second trimester and preeclampsia. Obstet Gynecol 2001;97:898–904.
   PubMed Web of Science ®Google Scholar
• ThadhaniR, MutterWP, WolfM, LevineRJ, TaylorRN, SukhatmeVP, EckerJ, KarumanchiSA. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk of preeclampsia. J Clin Endocrinol Metab 2004;89:770–775.
   PubMed Web of Science ®Google Scholar
• BrownMA, LindheimerMD, de SwietM, Van AsscheA, MoutquinJM. The Classification and diagnosis of the hypertensive disorders of pregnnacy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001;20:IX–XIV.
   PubMed Web of Science ®Google Scholar
• OngCY, LiaoAW, CachoAM, SpencerK, NicolaidesKH. First-trimester maternal serum levels of placenta growth factor as predictor of preeclampsia and fetal growth restriction. Obstet Gynecol 2001;98:608–611.
   PubMed Web of Science ®Google Scholar
• LawLW, SahotaDS, ChanLW, ChenM, LauTK, LeungTY. Effect of long term storage on placental growth factor (PlGF) and fms-like tyrosine kinase 1 (sFlt-1) measurements in samples from pregnant women. J Matern Fetal Neonatal Med, in press.
   Google Scholar
• PowersRW, RobertsJM, CooperKM, GallaherMJ, FrankMP, HargerGF, NessaRB. Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia. Am J Obstet Gynecol 2005;193:185–191.
   PubMed Web of Science ®Google Scholar
• AkolekarR, de CruzJ, FoidartJM, MunautC, NicolaidesKH. Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia. Prenat Diagn 2010;30:191–197.
   PubMed Web of Science ®Google Scholar
• MaynardSE, MinJY, MerchanJ, LimKH, LiJ, MondalS, LibermannTA, MorganJP, SellkeFW, StillmanIE, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649–658.
   PubMed Web of Science ®Google Scholar
• AkolekarR, SyngelakiA, BetaJ, KocylowskiR, NicolaidesKH. Maternal serum placental protein 13 at 11–13 weeks of gestation in preeclampsia. Prenat Diagn 2009;29:1103–1108.
   PubMed Web of Science ®Google Scholar
• De PacoC, KametasN, RencoretG, StroblI, NicolaidesKH. Maternal cardiac output between 11 and 13 weeks of gestation in the prediction of preeclampsia and small for gestational age. Obstet Gynecol 2008;111:292–300.
   PubMed Web of Science ®Google Scholar
• LeungTY, SpencerK, LeungTN, FungTY, LauTK. Higher median levels of free β-hCG and PAPP-A in the first trimester of pregnancy in a Chinese ethnic group. Implication for first trimester combined screening for Down's syndrome in the Chinese population. Fetal Diagn Ther 2006;21:140–143.
   PubMed Web of Science ®Google Scholar
• SahotaDS, LeungTY, FungTY, ChanLW, LawLW, LauTK. Medians and correction of biochemical and ultrasound markers in Chinese undergoing first trimester screening for Trisomy 21. Ultrasound Obstet Gynecol 2009;33:387–393.
   PubMed Web of Science ®Google Scholar
• WolfM, ShahA, LamC, MartinezA, SmirnakisKV, EpsteinFH, TaylorRN, EckerJL, KarumanchiSA, ThadhaniR. Circulating levels of the antiangiogenic marker sFLT-1 are increased in first versus second pregnancies. Am J Obstet Gynecol 2005;193:16–22.
   PubMed Web of Science ®Google Scholar